Evaluation of Double Tract Reconstruction After Total Gastrectomy in Patients With Gastric Cancer
NCT ID: NCT00746161
Last Updated: 2008-09-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
44 participants
INTERVENTIONAL
2002-04-30
2008-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Roux-en-Y
Reconstruction after total gastrectomy
Roux-en-Y
2
double tract reconstruction
Reconstruction after total gastrectomy
double tract reconstruction
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Reconstruction after total gastrectomy
Roux-en-Y
Reconstruction after total gastrectomy
double tract reconstruction
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age 80 years or younger
* No distant metastasis
Exclusion Criteria
* Stage intravenous (IV)
* History of laparotomy
* History of serious heart disease
* Liver cirrhosis or chronic liver disease with indocyanine green excretion test at 15 min of 15% or more
* Absence of informed consent
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Wakayama Medical University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Wakayama Medical University
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Makoto Iwahashi
Role: PRINCIPAL_INVESTIGATOR
Second Department of Surgery, Wakayama Medical University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Second Department of Surgery, Wakayama Medical University
Wakayama, Wakayama, Japan
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Iwahashi M, Nakamori M, Nakamura M, Naka T, Ojima T, Iida T, Katsuda M, Ueda K, Yamaue H. Evaluation of double tract reconstruction after total gastrectomy in patients with gastric cancer: prospective randomized controlled trial. World J Surg. 2009 Sep;33(9):1882-8. doi: 10.1007/s00268-009-0109-0.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
WMU-GC02
Identifier Type: -
Identifier Source: org_study_id